These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003. Burger H Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798 [TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance. Oddens BJ; Boulet MJ Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307 [TBL] [Abstract][Full Text] [Related]
7. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study. Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD; Menopause; 2000; 7(4):273-81. PubMed ID: 10914621 [TBL] [Abstract][Full Text] [Related]
8. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated]. Emons G; Westphalen S MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648 [TBL] [Abstract][Full Text] [Related]
10. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR; Gadducci A; Gambacciani M Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [TBL] [Abstract][Full Text] [Related]
11. [Menopause in 2004: "hormone replacement therapy" is not what it used to be anymore]. Azoulay C Rev Med Interne; 2004 Nov; 25(11):806-15. PubMed ID: 15501350 [TBL] [Abstract][Full Text] [Related]
14. Educating patients about the benefits and drawbacks of hormone replacement therapy. Rozenberg S; Vasquez JB; Vandromme J; Kroll M Drugs Aging; 1998 Jul; 13(1):33-41. PubMed ID: 9679207 [TBL] [Abstract][Full Text] [Related]
15. Use of alternatives to estrogen for treatment of menopause. Pinkerton JV; Santen R Minerva Endocrinol; 2002 Mar; 27(1):21-41. PubMed ID: 11845111 [TBL] [Abstract][Full Text] [Related]
16. The climacteric, osteoporosis and hormone replacement; views of women aged 45-49. Garton M; Reid D; Rennie E Maturitas; 1995 Jan; 21(1):7-15. PubMed ID: 7731387 [TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy in postmenopausal women. Yasui T; Uemura H; Takikawa M; Irahara M J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382 [TBL] [Abstract][Full Text] [Related]
18. [Hormone replacement therapy: curse or blessing?]. Schmidt M; Fink D; Lang U; Kimmig R Gynakol Geburtshilfliche Rundsch; 2006; 46(4):165. PubMed ID: 17068400 [TBL] [Abstract][Full Text] [Related]
19. The risks and benefits of hormonal replacement therapy in healthy women and in breast cancer survivors. Welnicka-Jaskiewicz M; Jassem J Cancer Treat Rev; 2003 Oct; 29(5):355-61. PubMed ID: 12972354 [TBL] [Abstract][Full Text] [Related]
20. Treatment of climacteric symptoms in survivors of gynaecological cancer. Biglia N; Bounous VE; Sgro LG; D'Alonzo M; Gallo M Maturitas; 2015 Nov; 82(3):296-8. PubMed ID: 26341044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]